GSK, GB0009252882

Voltaren Schmerzgel from GSK PLC - cooling gel, 60 g tube and clear focus on acute pain

Veröffentlicht: 29.06.2026 um 22:34 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)

Voltaren Schmerzgel 60 g targets sprains, bruises and joint pain with diclofenac in a quickly absorbed gel for adults and adolescents from 14 years. This bestseller stays in focus for holders of GSK shares (ISIN GB0009252882).

GSK, GB0009252882
GSK, GB0009252882

Reviewed: ad hoc news Bestseller & Flagship desk. Edited and checked on 2026-06-29, 22:33. Details in the imprint.

Voltaren Schmerzgel lands on the back of your hand as a cool, slightly medicinal-smelling strip, then disappears into the skin with a few firm strokes. The clear promise of the 60 g tube is simple pain relief for sprains, bruises and joint aches.

What this gel is made for

Voltaren Schmerzgel contains diclofenac, a non-steroidal anti-inflammatory drug that is applied directly to the skin over the painful area. The gel is designed for conditions such as sports and accident injuries, bruises, strains and mild osteoarthritis pain in superficial joints.

In everyday use, that means twisted ankles after running, a bruised shin from a coffee-table collision or a nagging knee after gardening are the typical scenarios where the blue-and-white tube comes out of the bathroom cabinet.

How it feels and is used

The gel spreads as a thin, slightly sticky film at first, then dries to a discreet, almost matte layer without leaving a greasy shine on clothes or bedsheets. Many users appreciate that the smell is present but quiet enough not to dominate a shared office or tram ride.

According to pharmacists, the usual recommendation for adults and adolescents from 14 years is to massage in a cherry- to walnut-sized amount of gel up to three times a day on the affected area, depending on size and pain intensity.

Go deeper

Background on GSK shares

Pain gels like Voltaren Schmerzgel are no longer part of GSK's core prescription portfolio, but the former consumer brands still shape how many retail investors remember the company.

Who still sees Voltaren at GSK

Corporate structure has shifted. Consumer brands such as Voltaren now sit with Haleon, the consumer health spin-off, while GSK concentrates on vaccines and prescription medicines. Yet for many small investors, former over-the-counter brands remain the mental link to GSK.

GSK chief executive Emma Walmsley regularly highlights in presentations that the separation was meant to give both companies clearer profiles: GSK for biopharma and vaccines, Haleon for everyday health brands from pain gels to toothpaste.

Strengths and limits in daily life

In practice, Voltaren Schmerzgel's main strength is targeted relief without swallowing a tablet, which some patients with sensitive stomachs welcome. The cooling sensation in the first minutes often gives a small psychological nudge that something is happening on the sore spot.

At the same time, the gel is not a cure-all for chronic, deep joint disease. Package information usually limits use to a few weeks and advises medical advice if pain persists, spreads or is accompanied by pronounced swelling or redness.

How pharmacies position the tube

German online pharmacies typically list a 60 g tube in the low double-digit euro range, often below the recommended retail price through discounts. The product is generally sold over the counter, with pharmacists advising on dosage, application intervals and compatibility with other medicines.

In physical pharmacies, Voltaren tends to sit at eye level in the pain and movement section, next to generic diclofenac gels and alternative ingredients such as ibuprofen, arnica or capsaicin creams. The familiar blue, orange and white branding still does much of the work in drawing the eye.

Where GSK shares stand

GSK PLC now reports in three main segments - vaccines, specialty medicines and general medicines - with blockbuster shingles vaccine Shingrix and HIV treatments like Dovato and Cabenuva often named as key profit drivers. The GSK share price (ISIN GB0009252882) is quoted on the London Stock Exchange in pence.

Key facts on Voltaren Schmerzgel

  • Product: Voltaren Schmerzgel 60 g
  • Manufacturer: Haleon Germany GmbH, a subsidiary of Haleon PLC, formerly part of GSK PLC
  • Category: Flagship/Bestseller over-the-counter pain gel
  • Launch: Earlier market introduction as a diclofenac gel, widely established in German-speaking pharmacies for years
  • RRP / Price: Typically in the low double-digit euro range for 60 g, with frequent pharmacy discounts
  • Availability: Over-the-counter in German pharmacies and online pharmacies, as well as in many European markets under the Voltaren brand
  • Target group: Adults and adolescents with acute musculoskeletal pain from sprains, bruises, strains or mild osteoarthritis in superficial joints
  • Highlight / USP: Local diclofenac application with a cooling, non-greasy gel texture that aims to combine targeted pain relief and a tidy skin feel

More perspectives and opinions

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | GB0009252882 | GSK | boerse | 69655605 | bgmi